Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 3, 2020

View Archived Issues

CAR-T therapy as powerful salvage approach in patients with R/R AL with TP53 alterations

PPARgamma controls antifibrotic network

Viral infection may be second hit for familial ALS

ZBP1 as a new therapeutic target in multiple myeloma

JNJ-7706621 reverses resistance to CD37-targeted radioimmunotherapy in DLBCL

Celgene presents first-in-human data for CC-90009

Cadila Healthcare divulges new antimycobacterial compounds

Chiesi Farmaceutici identifies ROCK1 and ROCK2 inhibitors

BioTheryX presents new compounds for cancer

Chemrar Research & Development Institute discloses dopamine D2 and D3 receptor agonists

New muscarinic M1 receptor antagonists presented by Pipeline Therapeutics

Durect discontinues development of DUR-928 for psoriasis

Opiant signs letter of intent with NCATS to collaborate on OPNT-004 development

Novel copy number genetic variants identified in Diamond Blackfan anemia

Orphazyme reports new data and analysis supporting arimoclomol in NPC

Phase III GRAVITAS-301 study of itacitinib in treatment-naive GvHD misses primary endpoint

Civi Biopharma studies PCSK9 inhibitor CIVI-007 in phase IIa study

Novan reports topline efficacy data from phase III B-SIMPLE program of SB-206 for molluscum

Glutamine transporter variant identified as new cancer target

Taiwan FDA approves Lumosa's IND for LT-5001 for uremic pruritus

Sol-Gel initiates phase I study of SGT-210 in punctate palmoplantar keratoderma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...